Drugs for Percutaneous Coronary Interventions
Percutaneous coronary intervention (PCI), such as balloon angioplasty or stent placement, predisposes to subsequent thrombosis. The current pharmacologic approach to prevention of this problem combines an anticoagulant with one or more antiplatelet drugs....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Drugs for Percutaneous Coronary Interventions
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1197
Article Code: 1197c
Date: December 6, 2004
Volume: 46
Page: 100
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1197
Article Code: 1197c
Date: December 6, 2004
Volume: 46
Page: 100
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)